These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6119808)

  • 1. Correlation of the chemical structure of 4-nitroquinolines inactivating human cytomegalovirus and established in vivo carcinogenicity tests.
    Albrecht T; Speelman DJ; Ramanujam VM; Lund HW; Legator MS; Trieff NM
    Teratog Carcinog Mutagen; 1980; 1(2):161-9. PubMed ID: 6119808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes virus inactivation by chemical carcinogens: differential inactivation of herpes simplex viruses by 4-nitroquinoline 1-oxide and related compounds.
    Speelman D; Li JL; Ramanujam VM; Legator MS; Albrecht T
    Environ Mutagen; 1981; 3(4):467-76. PubMed ID: 6266824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of human cytomegalovirus by the chemical carcinogen 4-nitroquinoline 1-oxide.
    Albrecht T; Speelman DJ; Li JL
    J Gen Virol; 1979 Oct; 45(1):231-6. PubMed ID: 230304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of 4-nitroquinoline 1-oxide to 4-hydroxyaminoquinoline 1-oxide in lysates of cytomegalovirus-infected cells.
    Speelman DJ; Lund H; Culling A; Kittredge JS; Williams BJ; Albrecht T
    J Gen Virol; 1983 Nov; 64 (Pt 11)():2511-5. PubMed ID: 6315869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analyses of differential sensitivities of synchronized HeLa S3 cells to radiations and chemical carcinogens during the cell cycle. III. 4-Nitroquinoline 1-oxide and its derivatives.
    Watanabe M; Horikawa M
    Mutat Res; 1975 May; 28(2):295-304. PubMed ID: 806013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A structure-carcinogenicity study of 4-nitroquinoline 1-oxides using the SIMCA method of pattern recognition.
    Dunn WJ; Wold S
    J Med Chem; 1978 Oct; 21(10):1001-7. PubMed ID: 102791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity of 4-nitroquinoline 1-oxide for Crithidia fasciculata.
    Leon W; Cruz FS; Vasconcellos ME
    J Protozool; 1975 May; 22(2):277-80. PubMed ID: 50443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vitro interaction of the carcinogens, 4-nitroquinoline-N-oxide and its metabolite 4-hydroxylaminoquinoline-N-oxide, with intact rat liver mitochondria.
    Hadler HI; Cao TM
    Chem Biol Interact; 1978 Feb; 20(2):219-26. PubMed ID: 417811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-Nitroquinoline-1-oxide: factors determining its mutagenicity in bacteria.
    McCoy EC; Petrullo LA; Rosenkranz HS; Mermelstein R
    Mutat Res; 1981 Jun; 89(2):151-9. PubMed ID: 6793865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Snuff tumorigenesis: effects of long-term snuff administration after initiation with 4-nitroquinoline-N-oxide and herpes simplex virus type 1.
    Larsson PA; Johansson SL; Vahlne A; Hirsch JM
    J Oral Pathol Med; 1989 Apr; 18(4):187-92. PubMed ID: 2549235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of 8-hydroxyguanine residues in cellular DNA exposed to the carcinogen 4-nitroquinoline 1-oxide.
    Kohda K; Tada M; Kasai H; Nishimura S; Kawazoe Y
    Biochem Biophys Res Commun; 1986 Sep; 139(2):626-32. PubMed ID: 3094520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects in rats of sodium chloride on experimental gastric cancers induced by N-methyl-N-nitro-N-nitrosoguanidine or 4-nitroquinoline-1-oxide.
    Tatematsu M; Takahashi M; Fukushima S; Hananouchi M; Shirai T
    J Natl Cancer Inst; 1975 Jul; 55(1):101-6. PubMed ID: 808633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between sensitivity of cells from patients with hereditary cutaneous malignant melanoma to killing and mutations by 4-nitroquinoline 1-oxide and adduct formation.
    Sato K; Howell JN; Greene MH; Maher VM; McCormick JJ
    Cancer Res; 1988 Sep; 48(18):5145-50. PubMed ID: 3136916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of the carcinogen 4-nitroquinoline 1-oxide with the non-protein thiols of mammalian cells.
    Varnes ME; Biaglow JE
    Cancer Res; 1979 Aug; 39(8):2960-5. PubMed ID: 110443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The distribution of carcinogens, 4-nitroquinoline-1-oxide and 4-hydroxyaminoquinoline-1-oxide, in the nervous system and its possible neurotoxicological significance.
    Takasu T
    Experientia; 1979 May; 35(5):668-70. PubMed ID: 109308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular biology of 4-nitroquinoline 1-oxide in the prokaryotic system.
    Kondo S
    Carcinog Compr Surv; 1981; 6():47-64. PubMed ID: 6786745
    [No Abstract]   [Full Text] [Related]  

  • 17. Formation of a cyclic adenine adduct with a 4-nitroquinoline N-oxide metabolite model.
    Tohme N; Demeunynck M; Lhomme MF; Lhomme J
    IARC Sci Publ; 1986; (70):241-5. PubMed ID: 3098679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection with adeno-associated virus type 5 inhibits mutagenicity of herpes simplex virus type 1 or 4-nitroquinoline-1-oxide.
    Schlehofer JR; Heilbronn R
    Mutat Res; 1990 Aug; 244(4):317-20. PubMed ID: 2166909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repair of DNA damage after exposure to 4-nitroquinoline-1-oxide in heterokaryons derived from xeroderma pigmentosum cells.
    Zelle B; Bootsma D
    Mutat Res; 1980 May; 70(3):373-81. PubMed ID: 6770261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of human cells persistently infected with cytomegalovirus and exposed to a chemical carcinogen.
    Li JL; Albrecht T
    Int J Cancer; 1982 Jan; 29(1):49-55. PubMed ID: 6277803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.